Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Schechter

Showing results (101-110 of 105) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 105 results.
Cornea|July 16, 2019
Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Corneal Staining in Patients With Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and Phase 3 StudiesRanjan Malhotra, Douglas K Devries, Jodi Luchs, et al.
Acta Oto-Laryngologica. Supplementum|November 23, 2006
Clinical trial to compare tinnitus masking and tinnitus retraining therapyJ A Henry, M A Schechter, T L Zaugg, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|August 3, 2019
Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Conjunctival Staining in Patients with Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and 3 Clinical TrialsRobert Smyth-Medina, Josh Johnston, Douglas K Devries, et al.
Journal of Cardiac Failure|September 15, 2015
Elevated Cardiac Troponin I in Preservation Solution Is Associated With Primary Graft DysfunctionMatthew A Schechter, Michael J Watson, Bryan J Feger, et al.
Plos One|August 14, 2014
Phosphoproteomic profiling of human myocardial tissues distinguishes ischemic from non-ischemic end stage heart failureMatthew A Schechter, Michael K H Hsieh, Linda W Njoroge, et al.
Pageof 11

Showing results (101-110 of 105) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 105 results.
Cornea|July 16, 2019
Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Corneal Staining in Patients With Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and Phase 3 StudiesRanjan Malhotra, Douglas K Devries, Jodi Luchs, et al.
Acta Oto-Laryngologica. Supplementum|November 23, 2006
Clinical trial to compare tinnitus masking and tinnitus retraining therapyJ A Henry, M A Schechter, T L Zaugg, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|August 3, 2019
Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Conjunctival Staining in Patients with Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and 3 Clinical TrialsRobert Smyth-Medina, Josh Johnston, Douglas K Devries, et al.
Journal of Cardiac Failure|September 15, 2015
Elevated Cardiac Troponin I in Preservation Solution Is Associated With Primary Graft DysfunctionMatthew A Schechter, Michael J Watson, Bryan J Feger, et al.
Plos One|August 14, 2014
Phosphoproteomic profiling of human myocardial tissues distinguishes ischemic from non-ischemic end stage heart failureMatthew A Schechter, Michael K H Hsieh, Linda W Njoroge, et al.
Pageof 11